<qa>  What is the name of the AZD1775?4. Patients must be able to swallow and tolerate oral medications and not have gastrointestinal illnesses that would preclude absorption of AZD1775 e.g. uncontrolled nausea, vomiting, or diarrhea; malabsorption syndrome; ulcerative disease. Note: Patient may not have a percutaneous endoscopic gastrostomy PEG tube or be receiving total parenteral nutrition TPN. 